News

NKTR-358 bolsters T-cells’ ability to respond to immune inflammatory disorders such as lupus, according to a preclinical-trial study. Nektar Therapeutics said its therapy increased levels of a subset of T-cells known as regulatory T-cells and reduced inflammation. It also generated fewer side effects than immunosuppressant drugs. The company presented the findings at the…

A study has identified several predictors of poor pregnancy outcomes in women with lupus, including disease flares less than six months before conception and use of  immunosuppressants. The research, “Predictors of poor obstetric outcome in women with systemic lupus erythematosus: a 10-year experience of a university hospital,”…

Korean patients with systemic lupus erythematosus (SLE) face a greater risk of autoimmune thyroid disease, a nationwide population-based study using health insurance claims data showed. The study, “Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based study in Korea,” recently appeared in the journal PLoS…

An ongoing online survey to examine the distribution of blood types among lupus patients could provide important information about why people develop the disease, researchers say. The survey is a collaboration between the University of Wisconsin–Madison and the Scleroderma Education Project. The two groups have already conducted a similar survey among…